Respivert Limited Patent applications |
Patent application number | Title | Published |
20160130256 | NOVEL COMPOUNDS - There are provided inter alia compounds of formula (I) | 05-12-2016 |
20160045512 | Inhibitors of Hemopoietic Cell Kinase (P59-HCK) and Their Use in the Treatment of Influenza Infection - The present invention relates inter alia to the treatment or prevention of influenza virus infection (including subtypes influenza A virus, influenza B virus, avian strain H5N1, A/H1N1, H3N2 and/or pandemic influenza) using compounds which inhibit the activity of p59-HCK and to a method of screening for a candidate drug substance intended to prevent or treat influenza virus infection in a subject, said method comprising identifying a test substance capable of inhibiting p59-HCK activity. | 02-18-2016 |
20160045482 | UREIDO-PYRAZOLE DERIVATIVES - The disclosure relates to compounds of formula (I) for use in the treatment or prophylaxis of rhinovirus infection, methods of treating or preventing rhinovirus infection employing said compounds or pharmaceutical composition comprising the same. The disclosure also relates to compounds of formula (I) for use in the treatment or prophylaxis of exacerbation of respiratory disorders (such as asthma, COPD, bronchitis and/or cystic fibrosis) by rhinovirus infection. | 02-18-2016 |
20150210722 | KINASE INHIBITORS - There are provided compounds of formula (I), | 07-30-2015 |
20140296271 | KINASE INHIBITOR - There is provided a compound of formula I, | 10-02-2014 |
20140296208 | KINASE INHIBITORS - There are provided compounds of formula I, | 10-02-2014 |
20140057915 | KINASE INHIBITORS - There are provided compounds of formula I, | 02-27-2014 |
20130231355 | QUINAZOLIN-4 (3H)- ONE DERIVATIVES USED AS P13 KINASE INHIBITORS - The present invention relates to the compound of formula (I) | 09-05-2013 |
20130156826 | RESPIRATORY FORMULATIONS AND COMPOUNDS FOR USE THEREIN - The present invention relates to respiratory formulations comprising a compound of formula (I): and use of said compounds and compositions in treatment, for example in the treatment of an inflammatory disease or a respiratory disorder, in particular an inflammatory mediated and/or virally mediated respiratory disorder such as asthma and COPD or the treatment or prevention of viral infection, for example infection by influenza virus, rhinovirus or RSV. The invention also extends to certain novel compounds of formula (I). | 06-20-2013 |
20130123260 | Methods - The disclosure relates to compounds of formula (I) for use in the treatment or prophylaxis of rhinovirus infection, methods of treating or preventing rhinovirus infection employing said compounds or pharmaceutical composition comprising the same. The disclosure also relates to compounds of formula (I) for use in the treatment or prophylaxis of exacerbation of respiratory disorders (such as asthma, COPD, bronchitis and/or cystic fibrosis) by rhinovirus infection. | 05-16-2013 |
20130102607 | UREIDO-PYRAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF RHINOVIRUS INFECTIONS - Medicinal use The disclosure relates to compounds of formula (I) for use in the treatment or prophylaxis of respiratory syncitial virus (RSV) infection in particular viral exacerbation of a respiratory disorder such as bronchitis, asthma, COPD and/or cystic fibrosis, methods of treating or preventing RSV infection employing said compounds or pharmaceutical composition comprising the same. | 04-25-2013 |